Secondary page header

The photo of San Francisco



Late Breaking Abstract Submissions Open!

Late Breaking Abstract Site Will Close on March 21, 2014.

General Information

Target Audience

The World Transplant Congress is designed to meet the educational needs of transplant physicians, surgeons, scientists, nurses, organ procurement personnel, pharmacists, and other healthcare professionals involved with solid organ and tissue transplantation.


A variety of formats are planned that will encourage the exchange of new scientific and clinical information and support an interchange of opinions regarding care and management as well as socioeconomic, ethical and regulatory issues relevant to organ and tissue transplantation.

Scientific material will be presented through symposia, concurrent workshops, peer reviewed oral and poster presentations as well as small parallel workshops designed for in-depth exploration of both clinical and basic science topics.


The purpose of the meeting is to:

  • Review and evaluate the latest clinical and basic science advances in transplantation science, medicine and surgery;
  • Investigate recent developments in transplant biology, immunology and organ preservation;
  • Examine the broad but critical issues in transplantation, including social and policy issues.

Submitting an abstract to the World Transplant Congress means that it will be peer reviewed and may be accepted for either an oral or a poster presentation. All accepted abstracts will be published online as supplements to The American Journal of Transplantation, the Joint Journal of the American Society of Transplant Surgeons (ASTS) and American Society of Transplantation (AST) and Transplantation, official Journal of The Transplantation Society. You may submit as many abstracts as you wish.

Abstract Notification

By March 24, 2014, all submitters will receive notification of their submitted abstracts status for the meeting. If you do NOT receive an email notification regarding your abstract by March 24th, please send an email inquiry to Technical Support at or call 1.507.403.2305.
Your email will receive a prompt answer. Inquiries before March 24, 2014 will not receive a response. All presenters are expected to cover their own travel and lodging and pay the registration fees.


In compliance with the Securities and Exchange Commission's Regulation FD (Fair Disclosure), the accepted abstracts are made available to the public on the WTC website and on both the American Journal of Transplantation and Transplantation journal websites. Thus, the first release of the abstracts is a public release. Coverage of additional research being presented at the congress is under embargo until the date of presentation.


Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract. However, the WTC continues to require that information that goes beyond that contained within the abstract, e.g., discussion of the abstract done as part of a scientific presentation, is to be embargoed until the start of the scientific sessions. Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Journalists failing to abide by the embargo may have their press credentials revoked.